Exact Sciences, Takeda & more: 4 GI company key notes

Here are four updates from gastroenterology companies from the past week:

The Royal Court of Jersey sanctioned Shire's proposed acquisition of Takeda Pharmaceuticals.

Exact Sciences expects to post fourth quarter 2018 revenues between $142.5 million to $143.5 million, a 64 percent year-over-year increase.

EnteraSense secured $4 million in funding for its gastrointestinal tract bleed-detecting capsule.

Landos Biopharma reported results from its phase 1 trial of BT-11, an ulcerative colitis and Crohn's disease treatment.

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Whitepapers

Featured Podcast